Effects of enoxaparin on late pregnancy complications and neonatal outcome in women with recurrent pregnancy loss and thrombophilia: Results from the Live-Enox study

  • B. B
  • J. B
  • M. E
  • et al.
N/ACitations
Citations of this article
1Readers
Mendeley users who have this article in their library.

Abstract

Women with thrombophilia and a history of recurrent pregnancy loss have poor pregnancy outcomes. Prophylaxis with enoxaparin 40 mg/day or 80 mg/day resulted in favorable gestational and neonatal outcomes. ©2005 by American Society for Reproductive Medicine.

Cite

CITATION STYLE

APA

B., B., J., B., M., E., I., Y., D., Y., & A., S. (2005). Effects of enoxaparin on late pregnancy complications and neonatal outcome in women with recurrent pregnancy loss and thrombophilia: Results from the Live-Enox study. Fertility and Sterility. B. Brenner, Thrombosis and Hemostasis Unit, Rambam Medical Center, PO Box 9602, Haifa 31096, Israel. E-mail: b_brenner@rambam.health.gov.il: Elsevier Inc. Retrieved from http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed7&NEWS=N&AN=2005418658

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free